Virtual specialty care company Summus raises $19.5M and more digital health fundings
18 Sep 2023
Preview
Source: mobihealthnews
Photo: Lacheev/Getty Images
Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.
Summus offers employers, health plans, hospitals and health systems, and medical groups and networks a virtual care platform focused on specialty care, including peer-to-peer solutions that allow primary care and in-plan specialist providers access to a specialist network.
The company will use the funds to scale its growth and innovation.
Last year, the New York-based company received a $22 million strategic investment from the Glenstone Foundation and Danaher Corporation's cofounder and executive committee chairman Mitchell Rales.
It secured $21 million in a Series B round less than a year before.
Healthy aging platform Bold announced it secured $17 million in Series A funding led by Rethink Impact, bringing its total raise to $27 million.
Samsung Next participated in the round alongside existing investors Andreessen Horowitz (a16z) Bio + Health, Primetime Partners, GingerBread Capital and Khosla Ventures.
Jenny Abramson, founder and managing partner of Rethink Impact, will join Bold's board of directors.
Bold partners with Medicare plans and providers to offer members virtual exercise programs aimed at preventing falls, increasing physical activity and reducing musculoskeletal pain and disability.
The funds will be used to grow the company's exercise offerings and support its expansion with national and regional provider groups and Medicare plans.
"Bold is at the forefront of a new paradigm in preventive health care for older adults that is founded in deep empathy for members and a thorough understanding of cutting-edge health science," Abramson said in a statement. "As the nation's population continues to age and Medicare costs balloon, we desperately need innovative, evidence-based solutions like Bold that meet people where they are and drive value across the healthcare system, from members to providers to payers."
Tags: Summus, Summus Global, Bold
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.